Celgene Corp (NASDAQ:CELG)

Monday’s trading has closed, but CELG is being traded in the after-hours session. After-Hours quote »
Data as of 3:59pm ET
 +3.88 / +4.40%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Celgene Corp. engages in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. It is dedicated to innovative research and development, which is designed to bring new therapies to market and is involved in research in several scientific areas such as immunomodulation and intracellular signaling pathways in hematology, oncology and immune-inflammatory diseases. Its portfolio of commercial products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax. Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Contact Information

Celgene Corp.
86 Morris Avenue
Summit New Jersey 07901
P:(908) 673-9000
Investor Relations:
(908) 673-9969



Mutual fund holders42.45%
Other institutional40.60%
Individual stakeholders1.19%

Top Executives

Robert J. HuginChairman & Chief Executive Officer
Mark J. AllesPresident & Chief Operating Officer
Peter N. KelloggChief Financial Officer & Executive Vice President
Jerome Bernard ZeldisChief Medical Officer & CEO-Global Health
Thomas O. DanielEVP, President-Research & Early Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.